On Friday, Applied Therapeutics Inc (NASDAQ: APLT) opened lower -4.92% from the last session, before settling in for the closing price of $0.54. Price fluctuations for APLT have ranged from $0.43 to $10.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 6.97% at the time writing. With a float of $92.20 million, this company’s outstanding shares have now reached $116.36 million.
The extent of productivity of a business whose workforce counts for 25 workers is very important to gauge. In terms of profitability, gross margin is 378.67%, operating margin of 43736.49%, and the pretax margin is 88772.51%.
Applied Therapeutics Inc (APLT) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Applied Therapeutics Inc is 20.76%, while institutional ownership is 84.07%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 32.27% during the next five years compared to -8.72% drop over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Check out the current performance indicators for Applied Therapeutics Inc (APLT). In the past quarter, the stock posted a quick ratio of 1.06.
Technical Analysis of Applied Therapeutics Inc (APLT)
The latest stats from [Applied Therapeutics Inc, APLT] show that its last 5-days average volume of 1.03 million was inferior to 3.58 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 31.68%. Additionally, its Average True Range was 0.06.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 0.82%, which indicates a significant decrease from 23.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.46% in the past 14 days, which was lower than the 244.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5586, while its 200-day Moving Average is $4.3748. Now, the first resistance to watch is $0.5457. This is followed by the second major resistance level at $0.5752. The third major resistance level sits at $0.5905. If the price goes on to break the first support level at $0.5009, it is likely to go to the next support level at $0.4856. Assuming the price breaks the second support level, the third support level stands at $0.4561.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are currently 116,356K shares outstanding in the company with a market cap of 60.07 million. Presently, the company’s annual sales total 9,990 K according to its annual income of -119,760 K. Last quarter, the company’s sales amounted to 120 K and its income totaled -68,590 K.
